NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 16.73% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 16.27% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.30% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 5.73% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 4.95% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 4.90% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 4.65% |
| MRUS | Merus BV | Healthcare | Biotechnology | 4.42% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 3.61% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 3.20% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.42% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.39% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.25% |
| MLTX_old | Multex Com Inc | Other | Other | 2.25% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.98% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.94% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.84% |